Reference Manual
The SCPP reference manual pulls together a number of resource documents related to guidelines , standards , policies , responsibilities, requirements, templates, forms and other information for pharmacy professionals.
Disclaimer: Printed copies of these documents may not be the most current version. The online version will be the most up to date. Although ongoing efforts are being made to ensure the accuracy of the information contained in these documents, please contact the College directly should you require additional clarity or have questions.
- Central Fill Pharmacy Agreement Template
- Central Fill Policy Statement
- Code of Ethics
- Low-Dose (Exempted) Codeine Products – Information for the Public
- Low-Dose (Exempted) Codeine Products – Conditions of Sale
- Cold Chain Management – Vaccine Storage, Handling and Transport Guidelines
- Cold Chain Management – Refrigerator and Temperature Monitoring Equipment Requirements
- Compliance Packaging – Customized Patient Medication Packaging Guidelines
- Compounding – NAPRA Model Compounding Competencies for Pharmacists and Pharmacy Technicians
- Compounding – NAPRA Model Standards for Pharmacy Compounding of Non-Sterile Preparations
- Compounding – NAPRA Guidance Document for Pharmacy Compounding of Non-Sterile Preparations
- Compounding – NAPRA Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations
- Compounding – NAPRA Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations
- Computer Requirements for Pharmacy Practice
- Criminal Record Check (CRC) Policy and FAQs
- D
- Data Sharing Agreement Template for Non-Trustees
- Depots: Direct Delivery of Pharmacy Services Policy
- Directors’ Duties and Responsibilities
- Drug Distribution by Prescription
- Provision of Drug Samples by Pharmacists Policy Statement
- E
- Electronic Transmission and Storage of Prescriptions
- Ethical Duty During an Emergency, Disaster or Pandemic for Pharmacists and Pharmacy Technicians
- Emergency – Exemptions for Prescribing Authority
- Emergency – Therapeutic Substitutions in Extraordinary Circumstances
- Emergency – Pharmacist Assessment Record (PAR) – Therapeutic Substitution
- Emergency Preparedness – Modifications to Pharmacy Operations and Hours
- Emergency Preparedness – Resource Kit for Pharmacists and Pharmacy Technicians
- Emergency – Registration and Licensure – Supplemental Policy
- F
- Forgeries
- Forgery Report Form for All Prescriptions Drugs
- H
- Hand Hygiene
- HIPA and PIPEDA – Preparing Your Community Pharmacy
- I
- Patient ID Verification
- Infection Control Guidelines
- Injections – Administration of Drugs by Injection and Other Routes Guidelines
- Injections – Administration of Drugs by Injection and Other Routes FAQs
- Injections – Needlestick Injury Guidelines
- Injections – Patient Self-Administered Injections – Guidelines for the Pharmacist
- L
- Laboratory Tests and Medical Devices (Accessing, Ordering, Performing, Using or Interpreting)
- Laboratory Tests – Performing Tests for Drug Therapy Management
- Laboratory Tests – Sale and Distribution of Medical Testing Devices and Other Diagnostic Products
- Language Proficiency – Pharmacy Technician Policy Statement
- Language Proficiency Requirements for Licensure as a Pharmacist in Canada (NAPRA)
- Language Proficiency Requirements for Licensure as a Pharmacy Technician in Canada (NAPRA)
- Library – Recommended Resources for Reference Library Requirements
- Long Term Care Facilities: Standards for Pharmacy Professionals Caring for Residents of Long-Term Care Facilities
- Low-Dose (Exempted) Codeine Products – Information for the Public
- Low-Dose (Exempted) Codeine Products – Conditions of Sale
- M
- Pharmacy Manager Policy
- MAID – Medical Assistance in Dying (Practitioner Administered) Standards for Pharmacists and Pharmacy Technicians
- Methadone Guidelines Replaced with Opioid Agonist Therapy (OAT) Standards
- Midwife Prescribing
- Dispensing Mifegymiso®: Guidance for Pharmacy Professionals
- N
- Narcotic and Controlled Drugs – Destruction of Controlled Substances
- Narcotic and Controlled Drugs – Guidelines for the Secure Distribution of Narcotic and Controlled Drugs in Hospitals
- Narcotic and Controlled Drugs – Loss or Theft Report Form (Health Canada)
- Narcotic and Controlled Drugs – Section 56 Exemption Communication
- Narcotic and Controlled Drugs – Narcotic and Controlled or Targeted Substances Reconciliation
- O
- Opioid Agonist Therapy (OAT) Standards
- Opioid Warning Sticker and Patient Information Handout Required to Accompany Dispensed Opioids
- Optometrists Prescribing Privileges
- Orientation to Practice Guide
- P
- Patient Assessment and Documentation Recommendations
- Patient ID Verification
- Pharmacist Assessment Record (PAR) - CDSA Drugs Maintenance Treatment Extension
- Pharmacist Assessment Record (PAR) – General
- Pharmacist Assessment Record (PAR) – Methadone Maintenance Treatment Extension
- Pharmacist Assessment Record (PAR) – Suboxone® Maintenance Treatment Extension
- Pharmacist Assessment Record (PAR) – Therapeutic Substitution
- Pharmacy Manager – Policy
- Pharmacy Manager – Responsibilities
- Pharmacy Manager – Suggested List of Ref. Manual Documents
- Pharmaceutical Waste Disposal Program
- NAPRA Principles of Professionalism for the Profession of Pharmacy
- Pharmacists – NAPRA Professional Competencies for Canadian Pharmacists at Entry to Practice
- Pharmacy – Pharmacy Closures (Temporary): Model Regulatory Policy Due to Pharmacist Absence
- Pharmacy – Professional Services Area – Delineation of the Pharmacy
- Pharmacy Technicians - Professional Competencies for Canadian Pharmacy Technicians at Entry to Practice (NAPRA)
- PIP – Policy Statement for Pharmacists and Pharmacy Technicians: Accessing Patient-Specific Information from the Medication Profile Viewer (MPV) Available Under the Pharmaceutical Information Program Policy (PIP)
- PIP – Guidelines for Pharmacists and Pharmacy Technicians: Accessing Patient-Specific Information from the Medication Profile View (MPV) Available Under the Pharmaceutical Information Program (PIP)
- PIP – Pharmaceutical Information Program (PIP) FAQ's
- PIP – Relevance of Data Quality to Pharmacy Practice
- Powers of Attorney, Health Care Directives and Substitute Decision Makers FAQs
- Powers of Attorney, Health Care Directives and Substitute Decision Makers Guidelines for Pharmacists and Pharmacy Technicians
- Prescriptive Authority – Decision Making Framework
- Prescriptive Authority – Pharmacists
- Prescriptive Authority – FAQs for the Public
- Prescriptive Authority – FAQs for Pharmacists
- Prescriptive Authority – FAQs for Hospital Pharmacies
- Prescriptive Authority – FAQs for Practitioners
- Prescriptive Authority – Framework for Developing a Safe and Functional Collaborative Practice Agreement
- Prescriptive Authority – Collaborative Practice (Prescribing) Agreement Template
- Prescribing Privileges – Interns and Residents – Prescribing Privileges
- Prescription Refills and Part Fills
- Prescription Review Program
- Prescription Validity – When Prescriber No Longer Practising
- Privacy & Disclosure – Patient Confidentiality and the Release of Confidential Records
- Privacy & Disclosure – Guidelines for Use and Disclosure of Personal Health Information for Secondary Purposes
- Privacy & Disclosure – Disclosure of Personal Health Information to Law Enforcement Authorities Guidelines for Pharmacists and Pharmacy Technicians
- Privacy & Disclosure – Disclosure of Personal Health Information to Third Parties – Position Statement
- Privacy & Disclosure – Release of Confidential Records of Minors to Parents/Guardians
- Privacy – SCPP Privacy Policies
- Privacy – Privacy Policies and Procedures Template for the Pharmacy
- Privacy Officer – Pharmacy Privacy Officer Bylaw and Interpretive Guidelines
- Privacy Officer – Suggested Position Description – Community Pharmacy Privacy Officer
- Q
- Standards of Practice – NAPRA Model Standards of Practice for Continuous Quality Improvement and Medication Incident Reporting Adapted
- Quality Improvement Reviews (QIRs)
- R
- Summary of Record-Keeping Requirements
- Record-Keeping Requirements for CDSA Drugs
- Refusal to Provide Products or Services for Moral or Religious Reasons Statement Regarding Pharmacists and Pharmacy Technicians
- Relief/Casual Pharmacists Policy Statement
- Respiratory Hygiene and Cough Etiquette
- S
- Satellite Proprietary Pharmacy Permit Criteria
- Scope of Practice – NAPRA Pharmacists’ Scope of Practice in Canadian Jurisdictions
- Scope of Practice – NAPRA Pharmacy Technicians' Scope of Practice in Canadian Jurisdictions
- Scope of Practice – Pharmacy Technicians Licensed in Saskatchewan
- Side Effect Reporting Form (Health Canada)
- Social Media Policy
- Standards of Practice for Saskatchewan Pharmacists
- Standards of Practice – NAPRA Model Standards of Practice for Pharmacists and Pharmacy Technicians in Canada
- Standards of Practice – NAPRA Model Standards of Practice for Continuous Quality Improvement and Medication Incident Reporting
- Standards of Practice – NAPRA Model Compounding Competencies for Pharmacists and Pharmacy Technicians
- Standards of Practice – NAPRA Model Standards for Pharmacy Compounding of Non-Sterile Preparations
- Standards of Practice – NAPRA Guidance Document for Pharmacy Compounding of Non-Sterile Preparations
- Standards of Practice – NAPRA Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations
- Standards of Practice – NAPRA Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations
- Standards of Practice – NAPRA Supplemental Standards of Practice for Schedule II and III Drugs
- Supervision of Pharmacy Interns
- T
- Termination of a Pharmacist-Patient Relationship
- Travel Health – Key Messages and Q-and-A for the Public
- Travel Health - Disease Prevention and Travel Health Services Policy and Framework for Saskatchewan Pharmacists
- Travel Health – Travel Health Services and Vaccine-Preventable Diseases FAQs
- Travel – Patients Sending or Travelling with Medications Outside of Canada
- U
- Understanding Prescriptions
- V
- Vaccine Storage, Handling and Transport Guidelines
- Guidelines for Pharmacists on Veterinary Use Medications
- Violence Policy Statement – Guidelines for Development